Related Experiment Videos
Peptides and cytokines
1Department of Dermatology, University of Kiel, Federal Republic of Germany.
Archives of Dermatological Research
|January 1, 1992
Summary
Inflammatory mediators like TNF alpha and IL-1 induce chemotactic cytokines, such as IL-8 and MCP-1, which attract specific immune cells. These cytokines, particularly IL-8 in psoriasis, play roles in inflammation, and their release can be pharmacologically inhibited.
Area of Science:
- Immunology
- Molecular Biology
- Dermatology
Background:
- Proteinaceous inflammatory mediators, including tumor necrosis factor alpha (TNF alpha) and Interleukin-1 (IL-1), exhibit pleiotropic effects.
- These cytokines are key inducers of a novel superfamily of structurally related low-molecular-weight chemotactic cytokines.
Purpose of the Study:
- To highlight the role of specific chemotactic cytokines, such as IL-8 and monocyte chemotactic protein-1 (MCP-1), in immune cell recruitment.
- To discuss the potential involvement of IL-8 in inflammatory conditions like psoriasis.
- To explore regulatory mechanisms and potential therapeutic interventions for these chemotactic cytokines.
Main Methods:
- Characterization of proteinaceous inflammatory mediators.
- Identification and classification of cell-selective chemotactic cytokines.
- Detection of IL-8 levels in psoriatic lesions.
- Discussion of regulatory pathways involving antagonists and potential pharmacological inhibition.
Main Results:
- Tumor necrosis factor alpha (TNF alpha) and Interleukin-1 (IL-1) stimulate the production of cell-selective chemotactic cytokines.
- IL-8 acts as a neutrophil attractant, while MCP-1 is a monocyte attractant.
- Elevated IL-8 levels are found in psoriatic lesions, correlating with neutrophil infiltration.
- Regulation of gene expression and release may involve IL-1 receptor antagonists and soluble TNF-alpha-receptors.
Conclusions:
- Chemotactic cytokines are crucial mediators of leukocyte recruitment, with specific roles for IL-8 and MCP-1.
- IL-8 may significantly contribute to the neutrophil-driven inflammation observed in psoriasis.
- While natural antagonists are not yet identified, pharmacological inhibition of chemotactic cytokine gene expression or release presents a potential therapeutic strategy.